Capital Advisory Group Advisory Services, LLC Innoviva, Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

  • $233 Million
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$14.32 - $19.88 $4,296 - $5,964
-300 Closed
0 $0
Q1 2022

Apr 29, 2022
BUY
$15.39 - $20.25 $4,617 - $6,075
300 New
300 $6,000
Q4 2021

Feb 15, 2022
SELL
$15.91 - $18.72 $4,773 - $5,616
-300 Closed
0 $0
Q1 2020

May 18, 2020
BUY
$8.11 - $15.23 $2,433 - $4,569
300 New
300 $4,000
Q4 2019

Feb 14, 2020
SELL
$10.28 - $14.38 $3,084 - $4,314
-300 Closed
0 $0
Q1 2018

May 28, 2020
BUY
$13.8 - $16.99 $4,140 - $5,096
300 New
300 $5,000

Others Institutions Holding INVA

# of Institutions
222
Shares Held
79.7M
Call Options Held
20K
Put Options Held
5.4K
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.36B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email